Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion type Assertion NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_head.
- NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion description "[This SRC pathway is essential for leukemic cells to survive imatinib treatment and for CML transition to lymphoid blast crisis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_provenance.
- NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion evidence source_evidence_literature NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_provenance.
- NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion SIO_000772 17077147 NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_provenance.
- NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion wasDerivedFrom befree-20140225 NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_provenance.
- NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_assertion wasGeneratedBy ECO_0000203 NP878740.RAefdCeCy8uLyHukHrE1bFwnfVLljB_WIqYMB_T5_-uss130_provenance.